Celltrion files for FDA approval for Remicade biosimilar

12-08-2014

Celltrion files for FDA approval for Remicade biosimilar

Christine Langer-Pueschel / Shutterstock.com

South Korean biopharmaceutical company Celltrion has applied for approval from the US Food and Drug Administration (FDA) to market a biosimilar version of Remicade (infliximab), it announced yesterday (August 11).


Celltrion, Remicade, Remsima, biosimilar, FDA

LSIPR